Aspire Pharma Limited
UK-MF-000051805 · United Kingdom · Surrey
Aspire Pharma Limited is registered in the European database on medical devices as a manufacturer, with 17 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
| Class IIa | 17 |
|---|
Among these devices, 1 are declared sterile.
Authorised representative in the Union: APIE Limited.
Devices declared under this manufacturer
- EPIMAX Excetra Cream 100g
- EPIMAX Excetra Cream 500g
- EPIMAX Gentle Wash 500g
- EPIMAX Isomol Gel 100g
- EPIMAX Moisturising Cream 100g
- EPIMAX Moisturising Cream 500g
- EPIMAX Oatmeal Cream 100g
- EPIMAX Oatmeal Cream 500g
- EPIMAX Ointment 125g
- EPIMAX Ointment 500g
- EPIMAX Original Cream 100g
- EPIMAX Paraffin-Free Ointment 500g
Showing 12 of 17 declared devices.
Catalogue references include 1010450, 1010454, 1010455, 1010477, 1010492, 1010493.
European nomenclature codes declared: V9099, Q0299.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 17 |
| Country of registration | United Kingdom |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 17 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. Aspire Pharma Limited was not found in either the U.S. or the Canadian register.